Johnson & Johnson MedTech(@JNJMedTech):The first Real-World VARIPULSE™ Pro Platform data was presented as a late-breaker at the Asia Pacific Heart Rhythm Society (APHRS) 2026 Annual Meeting in Busan, South Korea. VARIPURE evaluated 225 patients treated across 19 centers in Europe. Read the press release: https://t.co/zC2NVGENOb View the Europace publication: https://t.co/vDRJ6z7DSj *VARIPULSE Pro is not currently approved in the U.S. #PFA #Electrophysiology

Johnson & Johnson MedTech

@JNJMedTech

We are working to solve the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology.

Joined August 2017

209 Following 5.7K Followers

Johnson & Johnson MedTech@JNJMedTech

2026.10.22 12:01

The first Real-World VARIPULSE™ Pro Platform data was presented as a late-breaker at the Asia Pacific Heart Rhythm Society (APHRS) 2026 Annual Meeting in Busan, South Korea. VARIPURE evaluated 225 patients treated across 19 centers in Europe. Read the press release: View the Europace publication: *VARIPULSE Pro is not currently approved in the U.S. #PFA# #Electrophysiology#